LOTA S ZOTH Insider Trading $ONCE Spark Therapeutics, Inc.
Get free email notifications about insider trading for LOTA S ZOTH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOTA S ZOTH. LOTA S ZOTH is Chief Financial Officer in MEDIMMUNE INC /DE ($MEDI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in NEWLINK GENETICS CORP ($NLNK) and Director in Orexigen Therapeutics, Inc. ($OREX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Zymeworks Inc. ($ZYME) and CHIEF SCIENTIFIC OFFICER in Spark Therapeutics, Inc. ($ONCE) and Director in Spark Therapeutics, Inc. ($ONCE) and Director in 89bio, Inc. ($ETNB).
LOTA S ZOTH in Spark Therapeutics, Inc.
Trading Symbol: ONCEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of LOTA S ZOTH: CHIEF SCIENTIFIC OFFICER, Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2019
$ONCE Market Capitalization: $2.00B
$ONCE Previous Close: $63.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LOTA S ZOTH in Spark Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, HPTX, GEB, NLNK, MEDI, OREX, ONCE, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 37.18 | 12,000 | 446,160 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 37.18 | 12,000 | 446,160 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | CHIEF SCIENTIFIC OF ... | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Buy | M | 0.00 | 1,500 | 0 | 3,000 | 1.5 K to 3 K (+100.00 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Buy | M | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Buy | M | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
Jun 03 2016 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 56.22 | 6,000 | 337,320 | 6,000 | |
Jan 08 2016 | ONCE | Spark Therapeutics ... | Zoth Lota S. | Director | Option Exercise | A | 37.18 | 12,000 | 446,160 | 12,000 |
Page: 1